DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Rask-Andersen M, Masuram S, Schiöth HB.
The druggable genome: evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication.
Annual review of pharmacology and toxicology 2014;
54: 9-26
Access:
We do not assume any responsibility for the contents of the web pages of other providers.